326 related articles for article (PubMed ID: 22245495)
1. Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.
Ghosh AK; Nagpal V; Covington JW; Michaels MA; Vaughan DE
Cell Signal; 2012 May; 24(5):1031-6. PubMed ID: 22245495
[TBL] [Abstract][Full Text] [Related]
2. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of BRD4 attenuates transverse aortic constriction- and TGF-β-induced endothelial-mesenchymal transition and cardiac fibrosis.
Song S; Liu L; Yu Y; Zhang R; Li Y; Cao W; Xiao Y; Fang G; Li Z; Wang X; Wang Q; Zhao X; Chen L; Wang Y; Wang Q
J Mol Cell Cardiol; 2019 Feb; 127():83-96. PubMed ID: 30529267
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between endothelial cell-specific calpain inhibition and the endothelial-mesenchymal transition via the HSP90/Akt signaling pathway.
Sun X; Sun Y; Jiang P; Qi G; Chen X
Biomed Pharmacother; 2020 Apr; 124():109822. PubMed ID: 31958767
[TBL] [Abstract][Full Text] [Related]
5. MALAT1 Modulates TGF-β1-Induced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145.
Xiang Y; Zhang Y; Tang Y; Li Q
Cell Physiol Biochem; 2017; 42(1):357-372. PubMed ID: 28535533
[TBL] [Abstract][Full Text] [Related]
6. FGF2 inhibits endothelial-mesenchymal transition through microRNA-20a-mediated repression of canonical TGF-β signaling.
Correia AC; Moonen JR; Brinker MG; Krenning G
J Cell Sci; 2016 Feb; 129(3):569-79. PubMed ID: 26729221
[TBL] [Abstract][Full Text] [Related]
7. MiR-126-3p Is Dynamically Regulated in Endothelial-to-Mesenchymal Transition during Fibrosis.
Jordan NP; Tingle SJ; Shuttleworth VG; Cooke K; Redgrave RE; Singh E; Glover EK; Ahmad Tajuddin HB; Kirby JA; Arthur HM; Ward C; Sheerin NS; Ali S
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445337
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21.
Kumarswamy R; Volkmann I; Jazbutyte V; Dangwal S; Park DH; Thum T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):361-9. PubMed ID: 22095988
[TBL] [Abstract][Full Text] [Related]
9. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
Zhang H; Hu J; Liu L
Biomed Pharmacother; 2017 Nov; 95():215-222. PubMed ID: 28846982
[TBL] [Abstract][Full Text] [Related]
10. The Roles of Matrix Stiffness and ß-Catenin Signaling in Endothelial-to-Mesenchymal Transition of Aortic Valve Endothelial Cells.
Zhong A; Mirzaei Z; Simmons CA
Cardiovasc Eng Technol; 2018 Jun; 9(2):158-167. PubMed ID: 29761409
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-31 is a positive modulator of endothelial-mesenchymal transition and associated secretory phenotype induced by TGF-β.
Katsura A; Suzuki HI; Ueno T; Mihira H; Yamazaki T; Yasuda T; Watabe T; Mano H; Yamada Y; Miyazono K
Genes Cells; 2016 Jan; 21(1):99-116. PubMed ID: 26663584
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional regulation of endothelial-to-mesenchymal transition in cardiac fibrosis: role of myocardin-related transcription factor A and activating transcription factor 3.
Sharma V; Dogra N; Saikia UN; Khullar M
Can J Physiol Pharmacol; 2017 Oct; 95(10):1263-1270. PubMed ID: 28686848
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-β Signaling.
Kim J; Kim J; Lee SH; Kepreotis SV; Yoo J; Chun JS; Hajjar RJ; Jeong D; Park WJ
PLoS One; 2016; 11(11):e0166480. PubMed ID: 27835665
[TBL] [Abstract][Full Text] [Related]
14. A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis.
Du JK; Yu Q; Liu YJ; Du SF; Huang LY; Xu DH; Ni X; Zhu XY
Theranostics; 2021; 11(9):4207-4231. PubMed ID: 33754057
[No Abstract] [Full Text] [Related]
15. Foxm1 is a critical driver of TGF-β-induced EndMT in endothelial cells through Smad2/3 and binds to the Snail promoter.
Song S; Zhang R; Cao W; Fang G; Yu Y; Wan Y; Wang C; Li Y; Wang Q
J Cell Physiol; 2019 Jun; 234(6):9052-9064. PubMed ID: 30378114
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
[TBL] [Abstract][Full Text] [Related]
17. Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression.
Guo Y; Li P; Bledsoe G; Yang ZR; Chao L; Chao J
Exp Cell Res; 2015 Sep; 337(1):103-10. PubMed ID: 26156753
[TBL] [Abstract][Full Text] [Related]
18. The role of miR-328 in high glucose-induced endothelial-to-mesenchymal transition in human umbilical vein endothelial cells.
Chen Y; Yang Q; Zhan Y; Ke J; Lv P; Huang J
Life Sci; 2018 Aug; 207():110-116. PubMed ID: 29859985
[TBL] [Abstract][Full Text] [Related]
19. Dyssynchronous pacing triggers endothelial-mesenchymal transition through heterogeneity of mechanical stretch in a canine model.
Mai J; Hu Q; Xie Y; Su S; Qiu Q; Yuan W; Yang Y; Song E; Chen Y; Wang J
Circ J; 2015; 79(1):201-9. PubMed ID: 25373595
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
